The Moody Brain Health Institute (MBHI) at The University of Texas Medical Branch (UTMB) has announced the recipients of its 2026 pilot grant programs. Eight project teams were selected through two initiatives: the BRAIN Pilot Program (Bridging Research, AI & Neurodegeneration) and the Open Discovery Pilot Grant Program.
The programs support innovative, collaborative research aimed at advancing the understanding of brain health and neurodegenerative disease, encouraging new research approaches, and helping investigators build toward future external funding opportunities.
BRAIN Pilot Program awardees
The BRAIN Pilot Program supports research that uses artificial intelligence (AI) or machine learning as a core driver to address questions in neurodegeneration and build toward future R01 funding.
Congratulations to the four selected project teams:
- A Generative Digital Twin of Patient Clinical Trajectories for Calibrated Forecasting of the Path to Alzheimer's Disease: A Feasibility Study in Longitudinal EHR Data. Lead investigators: Kostiantyn Botnar, PhD, Department of Pharmacology and Toxicology, John Sealy School of Medicine; and Mukaila Raji, MD, FACP, Department of Internal Medicine, Division of Geriatrics, John Sealy School of Medicine
- VERITAS-CARE Pilot: Feasibility, Usability, and Preliminary Caregiver Impact of a Retrieval-Grounded Dementia Caregiver Support Platform. Lead investigators: Jonathan D. Hommel, PhD, Department of Pharmacology and Toxicology, John Sealy School of Medicine; and Allison Popovich, MD, Geriatric Psychiatry, John Sealy School of Medicine. Co-investigators and collaborators: Ardavan Borzou, PhD; Ara XIII; and Kamil Kanapov, PhD. Additional clinical, ethics, and caregiver-resource collaborators will be finalized
- From Renal Decline to Dementia Risk: A Cohort for the Kidney Brain Axis in CKD. Lead investigator: Ajay K. Israni, MD, Department of Internal Medicine, John Sealy School of Medicine. Co-investigators: Mukaila Raji, MD, Division of Geriatrics, Department of Internal Medicine, John Sealy School of Medicine; Kajal Gupta; Guillaume Onyeaghala; Michela Marcatti; Agenor Limon; and an MBHI computational scientist.
- NEST-AI Buildout: Multimodal Training and Prospective Validation for Neurodegenerative Phenotyping. Lead investigator: Courtney B. Woolsey, PhD, Department of Microbiology and Immunology, John Sealy School of Medicine.
Open Discovery Pilot Grant awardees
The Open Discovery Pilot Grant Program supports innovative, collaborative research that advances understanding of brain health and neurodegenerative disease while helping investigators develop future funding proposals.
Congratulations to the four selected project teams:
- Mechanistic Basis of Brain Resilience in Alzheimer's Disease. Lead investigator: Tapas Hazra, PhD, Department of Internal Medicine, John Sealy School of Medicine. Co-investigator: Anna Fracassi, PhD, Department of Neurology, John Sealy School of Medicine.
- Preclinical Development of HDAC6 Degraders as Disease-Modifying Therapeutics for Alzheimer's Disease. Lead investigator: Young-Hwan Jung, PhD, Department of Neurobiology, John Sealy School of Medicine, Sealy Institute for Drug Discovery, MBHI Fellow. Co-investigator: Claudia Marino, PhD, Department of Neurology, John Sealy School of Medicine, Sealy Institute for Drug Discovery, Mitchell Center for Neurodegenerative Diseases, MBHI Fellow
- ApoE3 Christchurch and ApoE4 Interactions Underlying Resilience and Susceptibility to Alzheimer's Disease. Lead investigator: Claudia Marino, PhD, Department of Neurology, John Sealy School of Medicine, Sealy Institute for Drug Discovery, Mitchell Center for Neurodegenerative Diseases, MBHI Fellow. Co-investigator: Maria-Adelaide Micci, PhD, Department of Anesthesiology, John Sealy School of Medicine.
- Supported Decision-Making Among Individuals With Cognitive Impairment and Dementia. Lead investigators: Rocksheng Zhong, MD, MHS, Psychiatry and Behavioral Sciences, John Sealy School of Medicine; and Karen Schlag, PhD, Internal Medicine, John Sealy School of Medicine. Co-investigators: Monique Pappadis, PhD, MEd, Population Health and Health Disparities, School of Public and Population Health; Mukaila Raji, MD, MS, Internal Medicine, John Sealy School of Medicine; and Melissa Morrow, PhD, Physical Therapy and Rehabilitation Sciences, School of Health Professions.
The Moody Brain Health Institute congratulates all eight project teams and their collaborators on their selection. Their work represents an important investment in advancing brain health research and developing new approaches to understanding and addressing neurodegenerative disease.